What is the paramedic treatment plan for a conscious adult patient with ventricular tachycardia (VT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paramedic Treatment Plan for Conscious VT Patient

For a conscious (hemodynamically stable) adult patient with ventricular tachycardia, administer amiodarone 150 mg IV over 10 minutes as first-line pharmacologic therapy, with synchronized cardioversion as the immediate backup if the patient becomes unstable or medication fails. 1

Initial Assessment and Stabilization

Confirm the rhythm is truly VT and assess hemodynamic stability immediately. 2

  • Look specifically for hypotension, altered mental status, signs of shock, chest pain, or acute heart failure symptoms 3, 2
  • If any of these signs develop, the patient is unstable and requires immediate synchronized cardioversion (see below) 3, 4
  • Establish IV access and prepare cardioversion equipment at bedside before administering any medications 5
  • Obtain a 12-lead ECG if time permits, but do not delay treatment 6

Pharmacologic Management for Stable Conscious VT

Amiodarone is the first-line antiarrhythmic for stable VT in the prehospital setting. 3, 1

Amiodarone Dosing Protocol:

  • Initial dose: 150 mg IV mixed in 100 mL D5W, infused over 10 minutes 1
  • This can be repeated for breakthrough VT episodes 1
  • After initial bolus, if transport time is prolonged, start maintenance infusion at 1 mg/min (360 mg over 6 hours) 1
  • The FDA label specifically indicates amiodarone for hemodynamically unstable VT, but it is the standard antiarrhythmic used in prehospital settings for stable VT as well 1

Critical Administration Points:

  • Use a volumetric infusion pump, not drop counters (which can underdose by up to 30%) 1
  • Monitor for hypotension during infusion—this is the most common acute side effect 1
  • For concentrations >2 mg/mL, use a central line if available; peripheral access is acceptable for short transport times at lower concentrations 1

Immediate Cardioversion Protocol

If the patient becomes unstable at any point or medication fails, perform immediate synchronized cardioversion. 3, 4

  • Initial energy: 100 joules synchronized (standard for monomorphic VT) 3
  • Ensure adequate sedation if the patient remains conscious (consider midazolam 2-5 mg IV or fentanyl 50-100 mcg IV if protocols allow) 3
  • Have defibrillation capability ready in case VT degenerates to VF 5
  • If standard cardioversion fails, consider double sequential cardioversion (two defibrillators simultaneously) for refractory VT 7

Critical Pitfalls to Avoid

Never administer calcium channel blockers (diltiazem, verapamil) or adenosine for wide-complex tachycardia. 3, 2, 5

  • These agents are for SVT only and can cause cardiovascular collapse or ventricular fibrillation in VT patients 3, 2
  • If there is any doubt whether the rhythm is VT versus SVT with aberrancy, treat as VT 2
  • Do not delay cardioversion to establish IV access in an unstable patient 3

Post-Conversion Management

After successful conversion to sinus rhythm, start an amiodarone maintenance infusion to prevent recurrence. 1, 4

  • Maintenance rate: 0.5 mg/min (720 mg over 24 hours) 1
  • Continue infusion during transport to definitive care 1
  • Monitor for atrial or ventricular premature complexes immediately after conversion 8
  • Reassess hemodynamic stability continuously, as VT may recur 4

Transport Considerations

  • Transport to a facility with cardiac catheterization and electrophysiology capabilities 9
  • Continuous cardiac monitoring and pulse oximetry throughout transport 6
  • Maintain IV access and keep cardioversion equipment immediately available 5
  • Brief receiving facility about rhythm, interventions performed, and patient response 6

References

Guideline

Management of Supraventricular and Ventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Management of Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ventricular Tachycardias: Characteristics and Management.

Critical care nursing clinics of North America, 2016

Guideline

Modified Valsalva Maneuver for Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ventricular tachycardia and ventricular fibrillation.

Expert review of cardiovascular therapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.